Connect Biopharma Holdings CNTB
NASDAQ CNTB
$0.80 -0.08 (-8.81%)
At close: Oct 21, 2026 · 4:00 PM EDT

Connect Biopharma Holdings (CNTB) EBT Margin (2024 - 2026)

Updated

Connect Biopharma Holdings (CNTB) posted EBT Margin of -622.25% for Q2 2026, up 26136.08 percentage points from -26758.33% a year earlier and up 10827.45 percentage points from the prior quarter.

Analysis

Connect Biopharma Holdings (CNTB) EBT Margin (2024 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, EBT Margin at Connect Biopharma Holdings was -2329.66%, down 55.82 percentage points year-over-year; for FY2025, it was -86379.69%, down 86320.51 percentage points from FY2024.

  • In prior years, Connect Biopharma Holdings' EBT Margin was -59.17% in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 40.25%
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 26.66%
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 25.18%
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -4.11%
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 29.63%
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 18.19%
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 27.53%
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -131.41%
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -4.34%
10 Connect Biopharma Holdings 49.92 Mn -126.76 Mn - -622.25%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -622.25%
Mar 31, 2026 -11,449.70%
Sep 30, 2025 -107,118.75%
Jun 30, 2025 -26,758.33%
Dec 31, 2024 -1,260.74%
Sep 30, 2024 -1,051.60%
API Access

Connect Biopharma Holdings EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=CNTB&period=max&api_key=YOUR_API_KEY